
Vivodyne
Vivodyne is developing advanced AI models for drug discovery and development.
About
Vivodyne revolutionizes therapeutics development by providing preclinical human data before clinical trials. Their platform utilizes ultra-realistic, lab-grown human organ tissue models and predictive AI to accelerate the discovery and optimization of new therapies. They partner with biopharma companies to advance new targets and bring better therapeutics to patients.
Key facts
At-a-glance profile data
- Website
- vivodyne.com
- Headquarters
- New York, United States
- Founded
- 2021
- Employees
- 41
- Total funding
- $40M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 31 May 2025 | Seed | $40M | - |
Tech stack
Detected on vivodyne.com and in its job posts, last scanned 4 Sept 2026. Run your own scan
- Frontend
- Bootstrap, React, Tailwind CSS, TypeScript
- Backend
- Python, FastAPI
- Database
- PostgreSQL
- Auth
- Auth0
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Hosting
- AWS
- Email provider
- Google Workspace
- Hiring platform
- Greenhouse
Add first review
Frequently asked
How much funding has Vivodyne raised?
Vivodyne has raised a total of $40M in funding. The most recent round on record is Seed.
How many employees does Vivodyne have?
Vivodyne has approximately 41 people on record.
